In a study by Hu et al., polymer-encapsulated curcumin and SOR significantly reduced the number of CD133+ HCC cells, although the authors did not verify whether CD44+ HCC cells were also affected by this NP 112. This evidence concerns the gene CD44 and hepatocellular carcinoma.